The role of FDG-PET in the interim evaluation of therapy response in diffuse large B-cell lymphoma

被引：0
|
作者：
Ellmann, Annare [1 ,2 ]
机构：
[1] Univ Stellenbosch, Cape Town, South Africa
[2] Tygerberg Hosp, Cape Town, South Africa
来源：
TRANSFUSION AND APHERESIS SCIENCE | 2013年 / 49卷 / 01期
关键词：
POSITRON-EMISSION-TOMOGRAPHY; NON-HODGKINS-LYMPHOMA; INTERNATIONAL HARMONIZATION PROJECT; SUV-BASED ASSESSMENT; PROGNOSTIC VALUE; F-18-FDG PET; MALIGNANT-LYMPHOMA; CHEMOTHERAPY; SCANS; FLUORODEOXYGLUCOSE;
D O I：
10.1016/j.transci.2013.05.023
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The significance of FDG PET in the interim follow-up of patients with diffuse large B-cell lymphoma to evaluate therapy response is currently being debated. Reports with discordant results have been published. Several authors have reported a low positive predictive value when using FDG PET to evaluate interim therapy response. Different criteria for the interpretation of PET studies in these patients are available, producing variable results. The latest publications and the review criteria will be summarised in this paper. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码：40 / 42
页数：3
相关论文
共 50 条
  • [21] Assessment of therapy response in lymphoma: Role of FDG-PET
    Julian, A.
    Wagner, T.
    Payoux, P.
    Hitzel, A.
    Esquerre, J. -P.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2011, 35 (01): : 21 - 28
  • [22] The Role of Interim PET/CT on Survival in Diffuse Large B Cell Lymphoma
    Menguc, Meral Ulukoylu
    Mehtap, Ozgur
    Gorur, Gozde Daglioz
    Atesoglu, Elif Birtas
    Geduk, Ayfer
    Unal, Serkan
    Tarkun, Pinar
    Hacihanefioglu, Abdullah
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (11) : E922 - E927
  • [23] Comparison of therapeutic evaluation criteria in FDG-PET/CT in patients with diffuse large-cell B-cell lymphoma: Prognostic impact of tumor/liver ratio
    Toledano, Mathieu N.
    Vera, Pierre
    Tilly, Herve
    Jardin, Fabrice
    Becker, Stephanie
    PLOS ONE, 2019, 14 (02):
  • [24] F-18 FDG PET/CT quantization parameters as predictors of outcome in patients with diffuse large B-cell lymphoma
    Gallicchio, Rosj
    Mansueto, Giovanna
    Simeon, Vittorio
    Nardelli, Anna
    Guariglia, Roberto
    Capacchione, Daniela
    Soscia, Ernesto
    Pedicini, Piernicola
    Gattozzi, Domenico
    Musto, Pellegrino
    Storto, Giovanni
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2014, 92 (05) : 382 - 389
  • [25] Role of FDG-PET/CT in detecting lymphomatous bone marrow involvement in patients with newly diagnosed diffuse large B-cell lymphoma
    Hong, Junshik
    Lee, Yukyung
    Park, Yeonjeong
    Kim, Seog Gyun
    Hwang, Kyung Hoon
    Park, Soon Ho
    Jeong, Jihoon
    Kim, Kyung-Hee
    Ahn, Jeong Yeal
    Park, Sanghui
    Park, Jinny
    Lee, Jae Hoon
    ANNALS OF HEMATOLOGY, 2012, 91 (05) : 687 - 695
  • [26] Interim PET Scans in Diffuse Large B-Cell Lymphoma: Is It Ready for Prime Time?
    Bolshinsky, Maital
    Nabhan, Chadi
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2016, 16 (12) : 655 - 661
  • [27] The role of FDG-PET imaging as a prognostic marker of outcome in primary mediastinal B-cell lymphoma
    Nagle, Sarah J.
    Chong, Elise A.
    Chekol, Seble
    Shah, Nirav N.
    Nasta, Sunita D.
    Glatstein, Eli
    Plastaras, John P.
    Torigian, Drew A.
    Schuster, Stephen J.
    Svoboda, Jakub
    CANCER MEDICINE, 2015, 4 (01): : 7 - 15
  • [28] Interim FDG-PET/CT for Response Assessment of Lymphoma
    Zeman, Merissa N.
    Akin, Esma A.
    Merryman, Reid W.
    Jacene, Heather A.
    SEMINARS IN NUCLEAR MEDICINE, 2023, 53 (03) : 371 - 388
  • [29] FDG-PET as a biomarker for early response in diffuse large B-cell lymphoma as well as in Hodgkin lymphoma? Ready for implementation in clinical practice?
    Zijlstra, Josee M.
    Burggraaff, Coreline N.
    Kersten, Marie Jose
    Barrington, Sally F.
    HAEMATOLOGICA, 2016, 101 (11) : 1279 - 1283
  • [30] Interim PET/CT based on visual and semiquantitative analysis predicts survival in patients with diffuse large B-cell lymphoma
    Li, Xiaoqian
    Sun, Xun
    Li, Juan
    Liu, Zijian
    Mi, Mi
    Zhu, Fang
    Wu, Gang
    Lan, Xiaoli
    Zhang, Liling
    CANCER MEDICINE, 2019, 8 (11): : 5012 - 5022
12345